Atara Biotherapeutics (ATRA) Asset Writedowns and Impairment (2025)

Atara Biotherapeutics (ATRA) has 1 years of Asset Writedowns and Impairment data on file, last reported at $4.1 million in Q1 2025.

• Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $4.1 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $4.1 million (changed N/A YoY) and the FY2025 annual result came in at $4.1 million, changed N/A from the prior year.
• Asset Writedowns and Impairment was little changed at $4.1 million in Q1 2025.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $4.1 million in Q1 2025 to a low of $4.1 million in Q1 2025.